Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0300
-0.0100 (-25.00%)
May 16, 2025, 4:00 PM EDT
Accelerate Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 11.7 | 12.06 | 12.75 | 11.78 | 11.17 | Upgrade
|
| Revenue Growth (YoY) | -2.99% | -5.43% | 8.23% | 5.53% | 20.09% | Upgrade
|
| Cost of Revenue | 8.99 | 9.51 | 9.45 | 12.16 | 6.71 | Upgrade
|
| Gross Profit | 2.7 | 2.55 | 3.3 | -0.38 | 4.46 | Upgrade
|
| Selling, General & Admin | 21.33 | 31.23 | 39.19 | 49.24 | 46.5 | Upgrade
|
| Research & Development | 16.69 | 25.35 | 26.92 | 21.94 | 21.26 | Upgrade
|
| Operating Expenses | 38.01 | 56.58 | 66.11 | 71.18 | 67.76 | Upgrade
|
| Operating Income | -35.31 | -54.03 | -62.81 | -71.56 | -63.3 | Upgrade
|
| Interest Expense | -13.12 | -7.74 | -3.77 | -15.55 | -15.55 | Upgrade
|
| Interest & Investment Income | 0.7 | 1.12 | 0.55 | 0.09 | 0.86 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.56 | 0.07 | 0.12 | -0.41 | 0.25 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.63 | 12.95 | -0.23 | -0.02 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -50.92 | -47.63 | -66.14 | -87.45 | -77.8 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.4 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.07 | 0.11 | - | - | - | Upgrade
|
| Other Unusual Items | 0.74 | -13.25 | 3.57 | 9.79 | - | Upgrade
|
| Pretax Income | -50.11 | -60.77 | -62.57 | -77.66 | -78.2 | Upgrade
|
| Income Tax Expense | -0.07 | 0.85 | -0.08 | 0.05 | 0.01 | Upgrade
|
| Net Income | -50.05 | -61.62 | -62.49 | -77.7 | -78.21 | Upgrade
|
| Net Income to Common | -50.05 | -61.62 | -62.49 | -77.7 | -78.21 | Upgrade
|
| Shares Outstanding (Basic) | 23 | 12 | 8 | 6 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 12 | 8 | 6 | 6 | Upgrade
|
| Shares Change (YoY) | 86.76% | 51.86% | 33.10% | 10.21% | 2.76% | Upgrade
|
| EPS (Basic) | -2.15 | -4.94 | -7.61 | -12.59 | -13.96 | Upgrade
|
| EPS (Diluted) | -2.15 | -4.94 | -7.61 | -12.59 | -14.00 | Upgrade
|
| Free Cash Flow | -24.7 | -41.23 | -49.28 | -47.93 | -51.76 | Upgrade
|
| Free Cash Flow Per Share | -1.06 | -3.31 | -6.00 | -7.76 | -9.24 | Upgrade
|
| Gross Margin | 23.11% | 21.15% | 25.90% | -3.23% | 39.94% | Upgrade
|
| Operating Margin | -301.85% | -448.03% | -492.51% | -607.37% | -566.95% | Upgrade
|
| Profit Margin | -427.81% | -510.97% | -490.06% | -659.50% | -700.47% | Upgrade
|
| Free Cash Flow Margin | -211.17% | -341.91% | -386.47% | -406.77% | -463.56% | Upgrade
|
| EBITDA | -31.89 | -50.77 | -59.81 | -69.04 | -60.3 | Upgrade
|
| EBITDA Margin | -272.60% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 3.42 | 3.25 | 3 | 2.52 | 3 | Upgrade
|
| EBIT | -35.31 | -54.03 | -62.81 | -71.56 | -63.3 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.